A share price of Exelixis Inc. [EXEL] is currently trading at $17.36, up 2.00%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EXEL shares have gain 6.37% over the last week, with a monthly amount glided 10.15%, and seem to be holding up well over a long-time horizon.
On 24, January 2023, Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023. In a post published today on Yahoo Finance, – Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT –.
From an analyst’s perspective:
Exelixis Inc. [NASDAQ: EXEL] stock has seen the most recent analyst activity on October 18, 2022, when JMP Securities initiated its Mkt Outperform rating and assigned the stock a price target of $26. Previously, BMO Capital Markets started tracking the stock with Outperform rating on June 24, 2022, and set its price target to $28. On November 19, 2021, Piper Sandler initiated with a Overweight rating and assigned a price target of $34 on the stock. Jefferies initiated its recommendation with a Buy and recommended $28 as its price target on October 07, 2021. H.C. Wainwright reiterated a Buy rating for this stock on August 06, 2021, and upped its price target to $64. In a note dated June 15, 2021, H.C. Wainwright initiated an Buy rating and iterated a target price of $47 on this stock.
Exelixis Inc. experienced fluctuations in its stock price throughout the past year between $14.87 and $23.40. Currently, Wall Street analysts expect the stock to reach $25.27 within the next 12 months. Exelixis Inc. [NASDAQ: EXEL] shares were valued at $17.36 at the most recent close of the market. An investor can expect a potential return of 45.56% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
During the last quarter, Exelixis Inc. [NASDAQ:EXEL] saw sales of 411.74 billion, an improvement of 25.40%. Gross Margin for this corporation currently stands at +96.32% with Operating Margin at +19.98%, Pretax Margin comes in at +20.50%, and Net Margin reading is +16.10%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.04 points at the first support level, and at 16.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.64, and for the 2nd resistance point, it is at 17.92.
Exelixis Inc. [EXEL] reported earnings per share of $0.22 for its fiscal quarter that ended on 6/29/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.19/share, meaning a difference of $0.03 and a surprise factor of 15.80%. By comparison, the stated earnings for the previous quarter ended on 3/30/2022 were $0.21 per share as compared to estimates of $0.14 per share, a difference of $0.07 representing a surprise of 50.00%.
Ratios To Look Out For
A current ratio of 6.10 is a noteworthy aspect of Exelixis Inc. [NASDAQ:EXEL]. As well, the Quick Ratio is 5.35, while the Cash Ratio is 4.35. Considering the valuation of this stock, the price to sales ratio is 4.11, the price to book ratio is 2.64 and the P/E (TTM) ratio is 18.29.
Transactions by insiders
Insider trading has also been a hot topic recently, with 3 insiders purchasing 160,000 shares and 7 selling 112,909 shares in the past 3 months. Recent insider trading involved Lamb Peter, EVP, Scientific Strategy & CSO, that happened on Dec 15 when 20000.0 shares were sold. Director, POSTE GEORGE completed a deal on Nov 29 to sell 40000.0 shares. Meanwhile, EVP, Commercial Haley Patrick J. sold 40000.0 shares on Sep 12.